Cytokines and the progression of liver damage in experimental bile duct ligation

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 4, 1999, Pages 358-363

  Plebani, Mario ^a,b   Piera Panozzo, Maria ^a   Basso, Daniela ^a   De Paoli, Massimo ^a   Biasin, Raffaella ^c   Infantolino, Domenico ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c NONE

Author keywords

Bile duct ligation; Cholestasis; Epidermal growth factor; Interleukin 6; Transforming growth factor 1; Tumour necrosis factor

Indexed keywords

EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ARTICLE; BILE DUCT LIGATION; CHOLESTASIS; CYTOKINE PRODUCTION; HISTOPATHOLOGY; LIVER BIOPSY; LIVER INJURY; MALE; NONHUMAN; PROTEIN DETERMINATION; RAT; TISSUE DISTRIBUTION;

ANIMALS; BILE DUCTS, INTRAHEPATIC; CHOLESTASIS, INTRAHEPATIC; CYTOKINES; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; INTERLEUKIN-6; LIGATION; LIVER; MALE; NECROSIS; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032930449     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.03042.x     Document Type: Article

References (31)

1. 1. Rees RC. Cytokines as biological response modifiers. Clin. Pathol. 1992; 45: 93-8.
2. 2. Enayati P, Brennan MF, Fong Y. Systemic and liver cytokine activation. Arch. Surg. 1994; 129: 1159-64.
3. 3. Andus T, Holstege A. Cytokines and the liver in health and disease. Effects on liver metabolism and fibrogenesis. Acta Gastroenterol. Belgica 1994; LVII: 236-44.
4. 4. McClain C, Hill D, Schmidt J, Diehl AM. Cytokines and alcoholic liver disease. Semin. Liver Dis. 1993; 13: 170-82.
5. 5. Tilg H. The role of cytokines in the pathophysiology of chronic liver diseases. Int. J. Clin. Lab. Res. 1993; 23: 179-85.
6. 6. Marti U, Burwen SJ, Jones AL. Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: An update. Hepatology 1989; 9: 126-38.
7. 7. Noble NA, Harper JR, Border WA. In vivo interactions of TGF-β and extracellular matrix. Progr. Growth Factor Res. 1992; 4: 369-82.
8. 8. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 1994; 331: 1286-92.
9. 1 and α in chronic liver diseases. Effects of interferon alpha therapy. N. Engl. J. Med. 1991; 324: 933-40.
10. 1 gene expression in human liver disease. J. Hepatol. 1992; 14: 259-64.
11. 11. Roberts AB, Sporn MB. Physiological action and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 1993; 8: 1-9.
12. 12. Miyazono K, Heldin CH. The mechanism of action of transforming growth factor-β. Gastroenterol. Jpn. 1993; 28: 81-5.
13. 13. Arai K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: Coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 1990; 59: 783-836.
14. 14. Van Deuren M, Dofferhoff ASM, Van Der Meer JWM. Cytokines and the response to infection. J. Pathol. 1992; 168: 349-56.
15. 15. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Biol. Rev. 1990; 70: 427-51.
16. 16. Trautwein C, Boker K, Manns MP. Hepatocyte and immune system: Acute phase reaction as a contribution to early defence mechanism. Gut 1994; 35: 1163-6.
17. 17. Rosser BG, Gores GJ. Liver cell necrosis: Cellular mechanisms and clinical implications. Gastroenterology 1995; 108: 252-75.
18. 18. Weiner FR, Degli Esposti S, Zern MA. A role for cytokines as regulators of hepatic fibrogenesis. Gastroenterol. Jpn. 1993; 28: 97-101.
19. 19. Marucci L, Svegliati Baroni G, Mancini R, Benedetti A, Jezequel AM, Orlandi F. Cell proliferation following extrahepatic biliary obstruction. J. Hepatol. 1993; 17: 163-9.
20. 20. Martinez OM, Villanueva JC, Greshwin ME, Krams SM. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995; 21: 113-19.
21. 21. Labarca C, Paigen K. A simple, rapid and sensitive DNA assay procedure. Anal. Biochem. 1980; 102: 344-52.
22. 22. Reichen R, Simon FR. Cholestasis. In: Arias IM, Jacoby WB, Popper H, Schatcher D, Shafritz DA (eds). The Liver: Biology and Pathobiology, 2nd edn. Raven Press, New York. 1988; 1105-24.
23. 23. Schaffner F, Bacchin PG, Hutterer F. Mechanisms of cholestasis. Structural and biochemical changes in the liver and serum in the rat after bile duct ligation. Gastroenterology 1971; 60: 888-97.
24. 24. Tevasaki M, Kuriki H, Nimura Y, Shinoya S, Kojima K, Yoshida S. Induction of DNA replication and cell growth in rat liver by obstructive jaundice. Jpn. J. Cancer Res. 1991; 282: 170-5.
25. 25. Slott PA, Lin MH, Tavoloni N. Origin, pattern and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology 1990; 99: 466-77.
26. 26. Alpini G, Lenzi R, Sarzoki L, Tavoloni N. Biliary physiology in rats with bile ductular cell hyperplasia. J. Clin. Invest. 1988; 81: 569-78.
27. 27. Ishii M, Vroman B, LaRusso NF. Morphologica demonstration of receptor-mediated endocytosis of epidermal growth factor by isolated bile duct epithelial cells. Gastroenterology 1990; 96: 1284-91.
28. 28. Castilla A, Prieto J, Fausto N. Transforming growth factors in human chronic hepatitis and cirrhosis: Correlations with fibrogenesis and hepatic regeneration. Gastroenterology 1991; 101: 1445-6.
29. 29. Boker K, Schwarting G, Kaule G, Gunzler V, Schmidt E. Fibrosis of the liver in rats induced by bile duct ligation. J. Hepatol. 1991; 13 (Suppl. 3): S35-40.
30. 30. Takiuchi H, Tada T, Li X-F et al. Particular types of tumor cells have the capacity to convert transforming growth factor β from a latent to an active form. Cancer Res. 1992; 52: 5641-6.
31. 31. Bemelmans MHA, Gouma DJ, Greve JW, Buurman WA. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology 1992; 15: 1132-6.